Company Filing History:
Years Active: 1997-1999
Title: Innovations in Diabetes Treatment by Jose M Hanquier
Introduction
Jose M Hanquier is a notable inventor based in Martinsville, IN (US), recognized for his contributions to the field of diabetes treatment. He holds a total of 4 patents, showcasing his commitment to advancing medical science and improving patient care.
Latest Patents
Among his latest innovations are the Acylated Insulin Analogs. This invention focuses on a monomeric insulin analog where the A chain retains the naturally occurring sequence of the human insulin A chain. The B chain is modified at either position B28 and B29 or both. The analog is mono-acylated at the N-terminal of the A chain or B chain or at the lysine. These acylated insulin analogs are designed to have an extended duration of action, providing significant benefits for diabetes management.
Career Highlights
Jose M Hanquier is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its innovative approaches to healthcare. His work at Eli Lilly has allowed him to focus on developing groundbreaking solutions for diabetes, contributing to the company's mission of improving lives through innovative medicines.
Collaborations
Some of his notable coworkers include Jeffrey C Baker and Victor J Chen, who collaborate with him on various projects aimed at enhancing diabetes treatment options.
Conclusion
Jose M Hanquier's work in developing acylated insulin analogs represents a significant advancement in diabetes treatment. His innovative approach and dedication to improving patient outcomes highlight the importance of research and development in the medical field.